Drug Trial Radar · NCT00459537
Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis
Last checked: Nov 19, 2026Latest source record: May 6, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,029
Actual
Start
Mar 2007
Primary completion
Jan 2009
Study completion Jan 2009
Sponsor
- Lead sponsor
- NovartisNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Apr 12, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy, safety and tolerability of topical 10% terbinafine hydrogen chloride applied daily versus 5% amorolfine nail lacquer applied twice a week in patients with mild to moderate toenail onychomycosis, for a total treatment duration of 48 weeks.
Conditions
- Onychomycosis
Interventions
terbinafine hydrogen chlorideDrug
10 % terbinafine hydrogen chloride (HCL)
amorolfine nail lacquerDrug
5 % amorolfine nail lacquer
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Complete Cure at the End of Study After Treating Participants for 48 WeeksTime frame: Week 52
- Percentage of Participants With Complete Cure at the End of Study After Treating Participants for 48 Weeks.Time frame: Week 52
Locations
10 sites in 10 countries. Site status is shown where the registry gives one.
Novartis Investigative Site
Various Cities, Finland
Novartis Investigative Site
Various Cities, France
Novartis Investigative Site
Various Cities, Germany
Novartis Investigative Site
Various Cities, Hungary
Novartis Investigative Site
Various Cities, Iceland
Novartis Investigative Site
Various Cities, Norway
Novartis Investigative Site
Various Cities, Poland
Novartis Investigative Site
Various Cities, Russia
Novartis Investigative Site
Various Cities, Spain
Novartis Investigative Site
Various Cities, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.